Corcept Therapeutics (CORT) earnings

Earnings (net income) · fiscal 2025
$99.65M

Corcept Therapeutics (CORT) reported net income of $99.65M in fiscal 2025 (the year ended December 31, 2025). That is 29.4% lower than the $141.21M of fiscal 2024. Figures as of 18 Nov 2026, 01:55 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Earnings (net income), fiscal 2025
$99.65M
Change on fiscal 2024
−29.4%
Growth, 5 years
−1.2% a year
Highest on record
$141.21Mfiscal 2024
Lowest on record
-$46.01Mfiscal 2013
Fiscal years on record
262000–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Corcept Therapeutics earnings, in more detail

Over the five fiscal years to 2025 net income shrank at a compound 1.2% a year. Across the 26 fiscal years on record (2000–2025), the highest was $141.21M in fiscal 2024 and the lowest -$46.01M in fiscal 2013.

History · 26 fiscal years

Earnings (net income) by fiscal year

Corcept Therapeutics earnings, year by year

Corcept Therapeutics (CORT) earnings by fiscal year
Fiscal yearEarnings (net income)ChangeYear ended
2025$99.65M 29.4% down
2024$141.21M 33.0% up
2023$106.14M 4.7% up
2022$101.42M 9.9% down
2021$112.51M 6.1% up
2020$106.01M 12.6% up
2019$94.18M 24.9% up
2018$75.41M 41.6% down
2017$129.12M 1,486.3% up
2016$8.14M—
2015-$6.41M—
2014-$31.38M—
2013-$46.01M—
2012-$38.05M—
2011-$32.35M—
2010-$25.97M—
2009-$20.17M—
2008-$20.06M—
2007-$11.57M—
2006-$24.87M—
2005-$20.09M—
2004-$15.54M—
2003-$9.81M—
2002-$18.50M—
2001-$7.45M—
2000-$1.85M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Earnings here means net income: what is left of the year's revenue after every cost, interest and tax, as reported on the income statement.

How to read it

Compare it across years rather than in isolation — one-off gains and write-downs can swing a single year a long way.

Earnings (net income) at health care companies of similar size

Earnings (net income) of Corcept Therapeutics and comparable companies
CompanyEarnings (net income)Fiscal year
10x Genomics TXG-$43.54M2025
HealthEquity HQY$215.20M2026
Corcept Therapeutics CORT$99.65M2025
Rhythm Pharmaceuticals RYTM-$196.54M2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on CORT

Corcept Therapeutics, figure by figure

Corcept Therapeutics (CORT) overview: price, valuation and scorecardAll health care companies by market value

Corcept Therapeutics earnings: questions and answers

What is Corcept Therapeutics's net income?

Corcept Therapeutics (CORT) reported net income of $99.65M in fiscal 2025 (the year ended December 31, 2025). That is 29.4% lower than the $141.21M of fiscal 2024.

What is the growth rate of Corcept Therapeutics's net income?

Over the five fiscal years to 2025 net income shrank at a compound 1.2% a year.

What are the highest and lowest net income figures on record for Corcept Therapeutics?

Across the 26 fiscal years on record (2000–2025), the highest was $141.21M in fiscal 2024 and the lowest -$46.01M in fiscal 2013.

How is Corcept Therapeutics's net income calculated?

Earnings here means net income: what is left of the year's revenue after every cost, interest and tax, as reported on the income statement.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Corcept Therapeutics (CORT) earnings”, data as of 18 November 2026. https://funkfolio.com/stock/CORT/earnings

Underlying data: the company's filings with the SEC and Yahoo Finance.